Trials & Tribulations Continuous temperature tracking helps manage infection risk after CAR T-cell therapy May 05, 2023Vol.49 No.18By Ruth Phillips
Lisa Coussens, Philip Greenberg, Andre Nussenzweig, Helen Piwnica-Worms, Richard D. Wood, and Shankar Balasubramanian are among newly elected NAS members May 05, 2023Vol.49 No.18By Jacquelyn Cobb
FreeIn the Archives AACI presidents 1991-2023 reflect on their presidential initiatives and cancer center leadership May 05, 2023Vol.49 No.18
With funds from Ralph Lauren, Georgetown Lombardi opens center for cancer prevention focused on health disparities April 28, 2023Vol.49 No.17By Matthew Bin Han Ong
Conversation with The Cancer Letter Georgetown takes cancer screening, prevention to underserved DC neighborhoods April 28, 2023Vol.49 No.17By Matthew Bin Han Ong
Conversation with The Cancer Letter David Lauren: We’re focused on cancer. This isn’t about just sending a check. This is our mission. April 28, 2023Vol.49 No.17By Matthew Bin Han Ong
Directors of NCI cancer centers say prevention, control, and health equity are key to reaching Moonshot goal April 28, 2023Vol.49 No.17By Paul Goldberg
FreeGuest Editorial A proposal for the Cancer Moonshot: Set up a strategic reserve for lifesaving generic cancer drugs April 28, 2023Vol.49 No.17By Satyajit Kosuri and Mark J. Ratain
Letter To The Editor Gary Schwartz: Monica Bertagnolli is poised to be a visionary NIH director April 28, 2023Vol.49 No.17By Gary Schwartz
FreeIn the Archives Patient stories: Sandra Hillburn on receiving a pathbreaking treatment for glioblastoma multiforme April 28, 2023Vol.49 No.17
